|
시장보고서
상품코드
1421546
세계의 발기부전 치료제 시장 - 주요 시장(2024-2029년)Global Erectile Dysfunction Treatment Market - Focused Insights 2024-2029 |
||||||
발기부전(ED)은 만족스러운 성행위나 성교에 충분한 음경 발기를 유지할 수 없는 상태가 지속되거나 재발하는 것으로, 일반적으로 발기부전이라고 불리며 가장 흔한 남성의 성 건강 장애 중 하나로 간주됩니다.
세계 발기부전 치료제 시장 규모는 2023년 47억 2,751만 달러로 평가되었고, 연평균 -0.94%의 연평균 복합 성장률(CAGR)을 나타낼 것으로 예상됩니다. 이 시장 규모는 주로 발기부전 유병률 증가에 기인하며, 당뇨병, 전립선 비대증, 전립선암, CVD와 같은 관련 만성 질환은 질병 발생의 고위험 요인이 될 수 있어 발기부전 치료제 시장의 중요한 요인으로 작용할 수 있습니다.
2023년 북미와 유럽이 각각 33.63%와 29.05% 시장 점유율로 시장을 장악했습니다. 아시아태평양은 연평균 2.70%의 연평균 복합 성장률(CAGR)을 나타낼 것으로 예측 기간 동안 수익 측면에서 가장 빠르게 성장하는 발기부전 치료제 시장이 될 것으로 예상됩니다.
제품별로는 의약품 부문이 79.08% 시장 점유율로 기기 부문을 압도했으며, 기기 부문은 20.92%의 점유율을 차지했습니다. 그러나 예측 기간 동안 기기 부문이 2억 5,258만 달러, 25.54%로 가장 높은 증분 성장률과 절대 성장률을 나타낼 것으로 보입니다.
발기부전 치료제의 투여 경로(RoA) 부문은 경구 약물, 음경 주사, 국소 약물로 세분화되며, 세 가지 하위 부문 중 경구 약물이 가장 큰 점유율을 차지하는데, 이는 브랜드 의약품물의 높은 채택률에 기인합니다. 전체적으로는 경구약이 92.57%, 음경 주사제가 4.70%, 국소 약품이 2.73%를 차지했습니다.
인식 증가, 질병 치료 및 관리를 위해 의료 지원을 받으려는 환자들의 의욕 증가, 발기부전 치료를 위한 약물 및 기기 사용을 권장하는 유리한 가이드라인의 존재감 증가는 예측 기간 동안 시장 성장을 가속할 것으로 예상됩니다.
이 보고서는 세계 발기부전 치료제 시장에 대해 조사했으며, 시장 개요, 지역별 동향, 시장 진출기업 프로파일 등의 정보를 제공합니다.
목차
제1장 발기부전 치료 시장 개요
제2장 발기부전 치료 시장
제3장 발기부전 치료 시장 세분화 데이터
제4장 주요 지역 개요
- 북미
- 유럽
- 아시아태평양
- 라틴아메리카
- 중동 및 아프리카
제5장 발기부전 치료 시장 전망과 기회
- 발기부전 치료 시장 기회와 동향
- 발기부전 치료 시장 성장 촉진요인
- 발기부전 치료 시장 성장 억제요인
제6장 발기부전 치료 업계 개요
- 발기부전 치료 시장 - 경쟁 구도
- 발기부전 치료 시장 - 주요 벤더 개요
- 발기부전 치료 시장 - 기타 저명한 벤더
- 발기부전 치료 시장 - 주요 전략적 추천 사항
제7장 부록
LSH 24.02.16REPORT OVERVIEW
This report offers market size & forecast data for the global erectile dysfunction treatment market. The revenue generated from the sale of drugs & devices is included in the report. This report provides a comprehensive and current market scenario of the global erectile dysfunction treatment market, including the global erectile dysfunction treatment market size, anticipated market forecast, relevant market segmentations, and industry trends.
The study considers a detailed scenario of the present global erectile dysfunction treatment market and its market dynamics for 2024-2029. It covers a detailed overview of several market growth enablers, restraints, and trends. The report offers both the demand and supply aspects of the market. It profiles and examines leading companies and other prominent players operating in the market.
MARKET DEFINITION
Erectile dysfunction (ED) is the condition that is a persistent or recurrent inability to attain and maintain penile erection sufficient to permit satisfactory sexual activity and intercourse. ED is commonly referred to as impotence and is considered one of the most common male sexual health disorders.
KEY HIGHLIGHTS
- The global erectile dysfunction treatment market was valued at $4,727.51 million in 2023 and registered a negative CAGR of -0.94%. The market reach is mainly attributed to the rising prevalence of erectile dysfunction and associated chronic diseases such as diabetes, benign prostate hyperplasia, prostate cancer, and CVDs, which can, in turn, pose high-risk factors for the occurrence of disease, are critical factors for the erectile dysfunction treatment market.
- In 2023, North America and Europe dominated the market with a market share of 33.63% and 29.05%, respectively. APAC is expected to be the fastest-growing market for erectile dysfunction treatment in terms of revenue during the forecast period, with a CAGR of 2.70%.
- Based on product, the drugs segment dominated the market over the devices segment and accounted for a market share of 79.08%, whereas the devices segment accounted for a 20.92% share. However, during the forecast period, the devices segment will likely witness the highest incremental and absolute growth of $252.58 million and 25.54%, respectively.
- The route of administration (RoA) segment of ED drugs is sub-segmented into oral medications, penile injections, and topical drugs. Among the three sub-segments, oral drugs occupied the largest share, which is attributed to the high adoption of branded drugs. Overall, 92.57% was occupied by oral drugs, followed by penile injections at 4.70% and topical drugs at 2.73%.
- Rising awareness, growing patient willingness to demand medical assistance for disease care and management, and the increasing presence of favorable guidelines that recommend the use of drugs and devices for the treatment of ED are expected to propel the market growth during the forecast period.
- Bayer, Pfizer, Eli Lilly and Company, Coloplast, and Boston Scientific are some of the leading players currently dominating the global erectile dysfunction treatment market. The major players focus on strategic acquisitions and collaborations with emerging players to enter the ED treatment market and gain access to commercially launched products.
VENDORS LIST
- Bayer
- Pfizer
- Coloplast
- Eli Lilly and Company
- Boston Scientific
- Teva Pharma
- Viatris
- Dong-A Socio
- Vivus
- Cristalia
- Dr.Reddy's
- Aurobindo
- Seelos Therapeutics
- Menarini Group
- GSK plc
- Futura Medical
- Sanofi
- Cipla
- Lupin
- Advanz Pharma
- Sandoz
- IX Biopharma
- Domier Medtech
- Zephyr Surgical Implants
- Augusta Medical Systems
- Metuchen Pharmaceuticals
- SK Chemicals
- Endo International
- Ferring Pharmaceuticals
- Alembic Pharmaceuticals
- Guangzhou Pharmaceuticals
- Launch Medical
- Bonro Medical
- Owen Mumford
- Direx Group
- Zimmer Medizin Systems
- MTS Medical UG
- Medispec
- Inceler Medical
- NOVAmedtek
- Wikkon
- Top Quality Group
- Promedon
- Timm Medical Technologies
- Global Life Technologies
- Urology Health Store
- Hims
REPORT HIGHLIGHTS
PRODUCT SEGMENTATION & FORECAST
- Product type
Drugs
Route of Administration
- Oral Drugs
- Penile Injections
- Topical Drugs
Distribution Channel
- Retail Pharmacies
- Hospital Pharmacies
- Online Portals
Devices
Type
- Penile Implants
- Vacuum Construction Devices
- Shock Wave Therapy
- Others
MARKET STRUCTURE
- Market Dynamics
- Competitive Landscape of ED Treatment Market
- Key Vendors
- Other Prominent Vendors
APPENDIX
- Research Methodology
- Abbreviations
- About Arizton
TABLE OF CONTENTS
CHAPTER - 1: ED Treatment Market Overview
- Executive Summary
- Key Findings
CHAPTER - 2: ED Treatment Market
- GLOBAL: Projected Revenue of ED Treatment Market (2023-2029; $Millions)
CHAPTER - 3: ED Treatment Market Segmentation Data
- GLOBAL: Projected Revenue by Product type (2022-2028; $ Millions)
Drugs
Route of Administration
- Oral Drugs
- Penile Injections
- Topical Drugs
Distribution Channels
- Retail Stores
- Hospital Pharmacies
- Online Portals
Devices
Type
- Penile Implants
- Vacuum Construction Devices
- Shock Wave Therapy
- Others
CHAPTER - 4: Key Regions Overview
- North America: Projected Revenue of ED Treatment Market (2023-2029; $Millions)
- Projected Revenue of ED Treatment Market in US
- Projected Revenue of ED Treatment Market in Canada
- Europe: Projected Revenue of ED Treatment Market (2023-2029; $Millions)
- Projected Revenue of ED Treatment Market in UK
- Projected Revenue of ED Treatment Market in Germany
- Projected Revenue of ED Treatment Market in France
- Projected Revenue of ED Treatment Market in Italy
- Projected Revenue of ED Treatment Market in Spain
- APAC: Projected Revenue of ED Treatment Market (2023-2029; $Millions)
- Projected Revenue of ED Treatment Market in Japan
- Projected Revenue of ED Treatment Market in China
- Projected Revenue of ED Treatment Market in India
- Latin America: Projected Revenue of ED Treatment Market (2023-2029; $Millions)
- Projected Revenue of ED Treatment Market in Brazil
- Projected Revenue of ED Treatment Market in Mexico
- Projected Revenue of ED Treatment Market in Argentina
- Middle East & Africa: Projected Revenue of ED Treatment Market (2023-2029; $Millions)
- Projected Revenue of ED Treatment Market in Saudi Arabia
- Projected Revenue of ED Treatment Market in South Africa
- Projected Revenue of ED Treatment Market in Turkey
CHAPTER - 5: ED Treatment Market Prospects & Opportunities
- ED Treatment Market Opportunities & Trends
- ED Treatment Market Drivers
- ED Treatment Market Constraints
CHAPTER - 6: ED Treatment Industry Overview
- ED Treatment Market - Competitive Landscape
- ED Treatment Market - Key Vendor Profiles
- ED Treatment Market - Other Prominent Vendors
- ED Treatment Market - Key Strategic Recommendations
CHAPTER - 7: Appendix
- Research Methodology
- Abbreviations
- About Arizton
